Aberrant glycosylation associated with enzymes as cancer biomarkers

BACKGROUND: One of the new roles for enzymes in personalized medicine builds on a rational approach to cancer biomarker discovery using enzyme-associated aberrant glycosylation. A hallmark of cancer, aberrant glycosylation is associated with differential expressions of enzymes such as glycosyltransf...

Descripción completa

Detalles Bibliográficos
Autores principales: Meany, Danni L, Chan, Daniel W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170274/
https://www.ncbi.nlm.nih.gov/pubmed/21906357
http://dx.doi.org/10.1186/1559-0275-8-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170274/
https://www.ncbi.nlm.nih.gov/pubmed/21906357
http://dx.doi.org/10.1186/1559-0275-8-7

Ejemplares similares